Concepedia

Malgorzata Szymańska

MS

Statistics

Publications

3

Citations

399

H-Index

3

Active since

2002

Affiliations

Poznan University of Medical Sciences(Current)

Malgorzata Szymańska is an author at Poznan University of Medical Sciences specializing in medicine, diabetology, and diabetes mellitus.

Publications per year

2002–2018

3

Publications

3

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 359 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

1,5-anhydro-D-glucitol: a novel marker of glucose excursions.

Marzena Dworacka, Hanna Winiarska, Malgorzata Szymańska et al. · PubMed · 2002 · 28 citations

Medicine, Biochemistry, Endocrinology +17

Serum Nξ-(Carboxymethyl)lysine is Elevated in Nondiabetic Coronary Heart Disease Patients

Marzena Dworacka, Hanna Winiarska, Malgorzata Szymańska et al. · Journal of Basic and Clinical Physiology and Pharmacology · 2002 · 12 citations

Medicine, Cardiology, Pharmacology +12

1–3 of 3